Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Fesarius Therapeutics logo — A cutting-edge NY-based biotech start-up on a mission to rev...

Fesarius Therapeutics

A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine.

Founded 2015 United States United States 8 employees Grant Total: $2.63M Biotechnology, Manufacturing

General Information

Company Name Fesarius Therapeutics
Founded Year 2015
Location United States United States +1
Employees 8
Industries Biotechnology, Manufacturing
Funding Stage Grant
Social

Get notified when Fesarius Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Fesarius Therapeutics

FesariusTherapeutics is a cutting-edge NY-based biotech start-up founded in 2015 with a mission to revolutionize the world of regenerative medicine. Their slogan, "A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine," reflects their dedication to innovation. The company focuses on developing innovative tissue-engineered products to transform reconstructive and aesthetic surgery. FesariusTherapeutics' flagship product, DermiSphere, is a revolutionary dermal regeneration template (DRT) for the management of wounds, based on technology spun-out from The Laboratory for Bioregenerative Medicine and Surgery at Weill Cornell Medicine. Their recent last investment of $800.00K Grant came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on 16th August 2023. This NY-based start-up operates within the Biotechnology and Manufacturing industries, solidifying its position as a pioneer in the field of regenerative medicine. With a focus on innovative technology and strong financial backing, FesariusTherapeutics is poised for significant growth and impact in the biotech space.

Taxonomy: Regenerative Medicine, Tissue Engineering, Dermal Regeneration, Wound Healing, Material Science, Skin Replacement, Dermatology, Start-up, Technology Innovation, Bioregenerative Medicine, Weill Cornell Medicine, Surgical Innovation, Research and Development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
16 Aug 2023
Grant •••••• 1 •••• •••• 08 Aug 2023
Seed Round •••••• 1 •••• •••• 11 Apr 2022

Fesarius Therapeutics Alternatives & Competitors

Fesarius Therapeutics vs
Animal Emergency & Referral Center of Minnesota
Animal Emergency & Referral Center of Minnesota United States

Passionate Care. Meaningful Relationships.

169 employees
Health Care
Fesarius Therapeutics vs
ACell
ACell

Developing and commercializing advanced extracellular matrix devices for effective tissue and organ...

Series Unknown
1001-5000 employees
Health Care, Manufacturing
Fesarius Therapeutics vs
CLINICA TUFET
CLINICA TUFET Spain

Clinic of Medicine and Cosmetic Surgery adapted to the new needs of the patients based on leaving no...

36 employees
Health Care, Health and Wellness

FAQ About Fesarius Therapeutics

A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine.
Fesarius Therapeutics was founded in 2015.
Fesarius Therapeutics is headquartered in United States.
Fesarius Therapeutics operates in the following industries: Biotechnology, Manufacturing.
Fesarius Therapeutics has approximately 8 employees.
Fesarius Therapeutics has completed 3 funding rounds, raising a total of $2.63M. The latest funding stage is Grant.
Top alternatives and competitors to Fesarius Therapeutics include Animal Emergency & Referral Center of Minnesota, ACell, CLINICA TUFET, OnLume, Beckman Laser Institute. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Fesarius Therapeutics and Animal Emergency & Referral Center of Minnesota are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Fesarius Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy